Pricing Log in Create free account

Citius Oncology, Inc. (CTOR) vs SCYNEXIS, Inc. (SCYX)

Citius Oncology, Inc. and SCYNEXIS, Inc. are both Drug Manufacturers Specialty & Generic companies. Citius Oncology, Inc. is the larger, with a market value of $69.4M against $38.9M — 1.8× the size. Citius Oncology, Inc. has the higher net margin (0.00% vs −49.7%) and the higher return on invested capital (−67.2% vs −110.7%). Across the 13 metrics below, SCYNEXIS, Inc. leads on 8 and Citius Oncology, Inc. on 5.

Valuation

Metric CTOR SCYX Drug Manufacturers Specialty & Generic median
P/E n/m n/m 19.25
P/S n/m 2.11 2.11
P/B 2.00 0.65 1.78
Price to free cash flow n/m n/m 16.14
EV/EBITDA n/m n/m 12.58
EV/Sales n/m 0.73 2.73
Earnings yield (62.67%) (56.95%) (4.38%)
Free cash flow yield (39.72%) (30.71%) 0.00%

Profitability

Metric CTOR SCYX Drug Manufacturers Specialty & Generic median
Gross margin — 100.00% 53.94%
Operating margin 0.00% (109.90%) 0.00%
Net margin 0.00% (49.74%) 0.00%
Free cash flow margin 0.00% (64.67%) 0.00%
Return on equity (126.58%) (18.38%) (0.40%)
Return on assets (45.20%) (15.09%) (3.32%)
Return on invested capital (67.15%) (110.72%) 0.00%

Growth

Metric CTOR SCYX Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — 682.47% 10.01%
EPS growth (last fiscal year) (9.68%) 61.36% 49.06%
Revenue growth, 5-year CAGR — 179.40% 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CTOR SCYX Drug Manufacturers Specialty & Generic median
Debt to equity 0.50 0.00 0.05
Current ratio 0.73 9.65 2.31
Net debt to EBITDA (0.40) 2.54 0.97

Dividend

Metric CTOR SCYX Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.57%
Payout ratio — — 0.27

Size

Metric CTOR SCYX Drug Manufacturers Specialty & Generic median
Market cap 69.36m 38.90m 276.90m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack